ArticleJournal of diabetes research2022

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography.

Magdalena Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.